자궁 내 염증이 동반된 임신에서 멜라토닌의 태아 보호 효과에 대한 고찰 = A Review on the Effects of Melatonin on Fetal Protection during Pregnancy with Intrauterine Inflammation

다국어 초록 (Multilingual Abstract)

Intrauterine inflammation is defined as the inflammation of the chorion, amnion, and placenta. Untreated inflammation increases the risk of fetal inflammatory response syndrome, which may result in multiorgan diseases involving the brain, cardiovascular system, lung, eye, and intestine. Therefore, controlling inflammation is critical in pregnant women to reduce the risk of diseases. However, there are no safe and effective anti-inflammatory drugs for administration during pregnancy. Although the primary function of melatonin is to control circadian rhythms, it has protective effects against cellular insults occurring from hypoxia, oxidative stress, and inflammation. While animal studies support the effective and safe role of melatonin in improving pregnancy-related morbidities, it leaves plenty of opportunities for clinical studies investigating its anti-inflammatory, antioxidant, and protective effects against insults induced by intrauterine inflammation. Therefore, it will be worthwhile to investigate antenatal supplementation of melatonin in pregnant women with intrauterine inflammation to reduce the incidence of associated comorbidities.

참고문헌 (Reference)

1 Kallapur SG, "Vascular changes after intra-amniotic endotoxin in preterm lamb lungs" 287 : L1178-L1185, 2004

2 El Frargy M, "Use of melatonin as an adjuvant therapy in neonatal sepsis" 8 : 227-232, 2015

3 Lal CV, "Ureaplasma infection-mediated release of matrix metalloproteinase-9 and PGP : a novel mechanism of preterm rupture of membranes and chorioamnionitis" 81 : 75-79, 2017

4 Hagberg H, "The role of inflammation in perinatal brain injury" 11 : 192-208, 2015

5 McAdams RM, "The role of cytokines and inflammatory cells in perinatal brain injury" 2012 : 561494-, 2012

6 Song J, "The protective effect of melatonin on neural stem cell against LPS-induced inflammation" 2015 : 854359-, 2015

7 Alghamdi BS, "The neuroprotective role of melatonin in neurological disorders" 96 : 1136-1149, 2018

8 Esmon CT, "The interactions between inflammation and coagulation" 131 : 417-430, 2005

9 Choi JY, "The effects of the severity of periventricular leukomalacia on the neuropsychological outcomes of preterm children" 31 : 603-612, 2016

10 Metzger RJ, "The branching programme of mouse lung development" 453 : 745-750, 2008

11 Claustrat B, "The basic physiology and pathophysiology of melatonin" 9 : 11-24, 2005

12 McCarthy R, "Riding the rhythm of melatonin through pregnancy to deliver on time" 10 : 616-, 2019

13 Collaco JM, "Respiratory phenotypes for preterm infants, children, and adults: bronchopulmonary dysplasia and more" 15 : 530-538, 2018

14 Mourani PM, "Pulmonary vascular disease in bronchopulmonary dysplasia : pulmonary hypertension and beyond" 25 : 329-337, 2013

15 Olegário JG, "Pulmonary innate immune response and melatonin receptors in the perinatal stress" 2013 : 340959-, 2013

16 Eloundou SN, "Placental malperfusion in response to intrauterine inflammation and its connection to fetal sequelae" 14 : e0214951-, 2019

17 Paredes SD, "Phytomelatonin : a review" 60 : 57-69, 2008

18 Bosma KJ, "Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome" 70 : 1255-1282, 2010

19 Folkerth RD, "Periventricular leukomalacia : overview and recent findings" 9 : 3-13, 2006

20 Hsu CN, "Perinatal use of melatonin for offspring health : focus on cardiovascular and neurological diseases" 20 : 5681-, 2019

21 Husain AN, "Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia" 29 : 710-717, 1998

22 Myatt L, "Oxidative stress in the placenta" 122 : 369-382, 2004

23 Gitto E, "Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns : beneficial effects of melatonin" 21 : 209-216, 2004

24 Tan DX, "One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?" 42 : 28-42, 2007

25 Østensen M, "Nonsteroidal anti-inflammatory drugs during pregnancy" 27 : 128-132, 1998

26 Sun FY, "Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia" 33 : 48-56, 2002

27 Volpe JJ, "Neurobiology of periventricular leukomalacia in the premature infant" 50 : 553-562, 2001

28 Stoll BJ, "Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network" 126 : 443-456, 2010

29 Romero R, "Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome" 133 : 1668S-1673S, 2003

30 Karasek M, "Melatonin, human aging, and age-related diseases" 39 : 1723-1729, 2004

31 Rodrigues Helmo F, "Melatonin treatment in fetal and neonatal diseases" 214 : 1940-1951, 2018

32 Deng WG, "Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding" 108 : 518-524, 2006

33 Welin AK, "Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion" 61 : 153-158, 2007

34 Pan L, "Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia" 5 : 216-221, 2009

35 Domínguez Rubio AP, "Melatonin prevents experimental preterm labor and increases offspring survival" 56 : 154-162, 2014

36 Sagrillo-Fagundes L, "Melatonin in pregnancy : effects on brain development and CNS programming disorders" 22 : 978-986, 2016

37 Brzezinski A, "Melatonin in Humans" 336 : 186-195, 1997

38 Lee JY, "Melatonin for prevention of placental malperfusion and fetal compromise associated with intrauterine inflammation-induced oxidative stress in a mouse model" 67 : e12591-, 2019

39 Lee JY, "Melatonin for prevention of fetal lung injury associated with intrauterine inflammation and for lung maturation" 69 : e12687-, 2020

40 Tricoire H, "Melatonin enters the cerebrospinal fluid through the pineal recess" 143 : 84-90, 2002

41 Chen HY, "Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood–brain barrier permeability after transient focal cerebral ischemia in mice" 41 : 175-182, 2006

42 Chung SY, "Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition" 34 : 95-102, 2003

43 Lanoix D, "Melatonin : the watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation-induced oxidative stress and apoptosis" 381 : 35-45, 2013

44 Yawno T, "Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia" 34 : 543-551, 2012

45 Watanabe K, "Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain" 37 : 276-280, 2004

46 Thibeault DW, "Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease" 106 : 1452-1459, 2000

47 Lee MY, "Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats" 42 : 297-309, 2007

48 Gomez-Lopez N, "Intra-amniotic administration of lipopolysaccharide induces spontaneous preterm labor and birth in the absence of a body temperature change" 31 : 439-446, 2018

49 Collins JJP, "Inflammation in fetal sheep from intraamniotic injection of Ureaplasma parvum" 299 : L852-L860, 2010

50 Romero R, "Human decidua : a source of cachectin-tumor necrosis factor" 41 : 123-127, 1991

51 Yoon BH, "High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia" 177 : 406-411, 1997

52 Balinotti JE, "Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy" 181 : 1093-1097, 2010

53 Kallapur SG, "Fetal immune response to chorioamnionitis" 32 : 56-67, 2014

54 Yoon BH, "Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits" 177 : 797-802, 1997

55 Higgins RD, "Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis : summary of a workshop" 127 : 426-436, 2016

56 Sánchez A, "Evaluating the oxidative stress in inflammation : role of melatonin" 16 : 16981-17004, 2015

57 Goldenberg RL, "Epidemiology and causes of preterm birth" 371 : 75-84, 2008

58 Munshi UK, "Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia" 24 : 331-336, 1997

59 Wenstrom KD, "Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery" 178 : 546-550, 1998

60 Gitto E, "Effects of melatonin treatment in septic newborns" 50 : 756-760, 2001

61 Bell MJ, "Effects of intrauterine inflammation on developing rat brain" 70 : 570-579, 2002

62 Gitto E, "Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin" 36 : 250-255, 2004

63 Wu YH, "Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: Colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone" 499 : 897-910, 2006

64 Ambalavanan N, "Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants" 123 : 1132-1141, 2009

65 Gitto E, "Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns:improvement with melatonin treatment" 39 : 287-293, 2005

66 Bourbon J, "Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia" 57 : 38-46, 2005

67 Gantert M, "Chorioamnionitis: a multiorgan disease of the fetus?" 30 : S21-S30, 2010

68 Gavilanes AW, "Chorioamnionitis induced by intraamniotic lipopolysaccharide resulted in an intervaldependent increase in central nervous system injury in the fetal sheep" 200 : 437.e1-437.e8, 2009

69 Wu YW, "Chorioamnionitis as a risk factor for cerebral palsy : a meta-analysis" 284 : 1417-1424, 2000

70 Nakamura Y, "Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy" 30 : 29-33, 2001

71 Stavsky M, "Cerebral palsy—trends in epidemiology and recent development in prenatal mechanisms of disease, treatment, and prevention" 5 : 21-, 2017

72 Strijbis EMM, "Cerebral palsy and the application of the International Criteria for Acute Intrapartum Hypoxia" 107 : 1357-1365, 2006

73 Graham HK, "Cerebral palsy" 2 : 15082-, 2016

74 Malpaux B, "Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin" 16 : 336-347, 2001

75 Villamor-Martinez E, "Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants : a systematic review, meta-analysis, and metaregression" 2 : e1914611-, 2019

76 Ray A, "Antibiotics prior to amniotomy for reducing infectious morbidity in mother and infant" (10) : CD010626-, 2014

77 Gravett MG, "An experimental model for intraamniotic infection and preterm labor in rhesus monkeys" 171 : 1660-1667, 1994

78 Yoon BH, "Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy" 177 : 19-26, 1997

79 Lee JY, "Administration of melatonin for prevention of preterm birth and fetal brain injury associated with premature birth in a mouse model" 82 : e13151-, 2019

80 Deacon S, "Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans" 178 : 32-34, 1994

81 Kim CJ, "Acute chorioamnionitis and funisitis : definition, pathologic features, and clinical significance" 213 : S29-S52, 2015

82 Mauriz JL, "A review of the molecular aspects of melatonin's anti-inflammatory actions : recent insights and new perspectives" 54 : 1-14, 2013

83 Tomás-Zapico C, "A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes" 39 : 99-104, 2005